Yazen Health, a telehealth platform targeted at patients with obesity-related health conditions, has closed a €19.5M Series A funding round. With this funding, the company plans to expand internationally.

The funding round was co-led by Evli Growth Partners and Helsana HealthInvest with participation from Almaz Capital and Yabeo. Existing Swedish investors Luminar Ventures and Aggregate Media participated.

The company is already profitable in the Swedish market and the new financing will be used to further scale the business internationally, including Spain, Norway, and the Netherlands while also strengthening their pilot markets in the UK and Germany.

The investment will also enable development of Yazen’s app and care service by connecting doctors, YazenCoaches, psychologists, dietitians, and physiotherapists to patients. Yazen has accrued over 20,000 patients in Sweden, with a 70 percent retention rate after one year.

“We are extremely proud of what we’ve achieved so far and the strong growth we’ve seen in Sweden. This funding gives us the opportunity to continue our mission to defeat obesity on a global scale. With Mikael Hed as our new Chairman and the support of our new investors, we are better positioned than ever to make a difference,” said Fredrik Meurling, CEO and Founder of Yazen.

“Yazen’s comprehensive offering has quickly demonstrated an impressive track record. I look forward to leading the board’s work and, together with both existing and new investors, continuing Yazen’s international expansion.” added Mikael Hed, Growth Partner at Evli Growth Partners.